Yanai, H. et al. 2025. Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes. Journal of Clinical Medicine Research. 17, 9 (Oct. 2025), 469–489. DOI:https://doi.org/10.14740/jocmr6370.